Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF [NA]

View source ↗

Summary

Clinical trial registry entry describing balloon-based pulsed-field ablation for paroxysmal and persistent atrial fibrillation, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PFA Balloon Ablation Device

Snippet

Sponsor: Abbott Medical Devices | Conditions: Paroxysmal AF, Atrial Arrhythmia | NA | Status: RECRUITING